RecruitingNot ApplicableNCT06110091

Multi-center Trial to Improve Nocturia and Sleep in Older Adults

Multi-center Trial to Improve Nocturia and Sleep in Older Adults (MINT)


Sponsor

Atlanta VA Medical Center

Enrollment

192 participants

Start Date

Dec 5, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The Multi-center Trial to Improve Nocturia and Sleep in Older Adults (MINT) study is a randomized trial to determine and assess the efficacy of integrated treatment of coexisting nocturia and insomnia, as well as explore the effects of this treatment on quality of life.


Eligibility

Min Age: 60 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a behavioral approach called Health Education Program and Integrated Behavioral Therapy Program for people with insomnia and nocturia. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 60 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALIntegrated Behavioral Therapy Program

Integrated Behavioral Therapy is a behavioral program that includes education, lifestyle habits management, cognitive, relaxation, and behavioral conditioning for nocturia and insomnia

BEHAVIORALHealth Education Program

Health Education Program modules focus on brain health and includes topics such physical activity, social engagement, sleep topics (e.g., changes in sleep that occur with aging, effects of poor sleep on health), medications/medical conditions, vision and hearing impairment.


Locations(2)

VA Greater Los Angeles Healthcare System

Los Angeles, California, United States

Atlanta VAHCS

Atlanta, Georgia, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06110091


Related Trials